Cost-effective diagnosis of acoustic neuromas: A philosophical, macroeconomic, and technological decision

Otolaryngology - Head and Neck Surgery

Volumn 127, Issue 4, 2002, Pages 253-259

  Murphy, Mark R ^b   Selesnick, Samuel H ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ACOUSTIC NEURINOMA; ARTICLE; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DIAGNOSTIC TEST; DRUG COST; EVOKED AUDITORY RESPONSE; HUMAN; NEURILEMOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; SOCIOECONOMICS; TECHNOLOGY; COST BENEFIT ANALYSIS; ECONOMICS; EVOKED BRAIN STEM AUDITORY RESPONSE; EVOKED RESPONSE AUDIOMETRY; FEMALE; HEALTH CARE COST; MALE; METHODOLOGY; NEUROMA; REVIEW; UNITED STATES;

AUDIOMETRY, EVOKED RESPONSE; COST-BENEFIT ANALYSIS; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; GADOLINIUM DTPA; HEALTH EXPENDITURES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROMA, ACOUSTIC; UNITED STATES;

EID: 0036782712     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhn.2002.128071     Document Type: Article

References (29)

1. Howitz MF, Johansen C, Tos M, et al. Incidence of vestibular schwannoma in Denmark. 1977-1995. Am J Otol 2000;21:690-4.
2. Anderson TD, Loevner LA, Bigelow DC, et al. Prevalence of unsuspected AN found by magnetic resonance imaging. Otolaryngol Head Neck Surg 2000;122:643-6.
3. Mirz F, Jorgensen BG, Pedersen CB. Vestibular schwannoma. Incidence of the disease and the consequences. Ugeskrift Laeger 1998;160:6516-9.
4. Tos M, Charabi S, Thomsen J. Clinical experience with vestibular schwannoma: epidemiology, symptomatology, diagnosis, and surgical results. Eur Arch Otorhinolaryngol 1998;255:1-6.
5. Selesnick SH, Jackler RK, Pitts LW. The changing clinical presentation of acoustic tumors in the MRI era. Laryngoscope 1993;103:431-6.
6. Edwards CH, Patterson JH. A review of the symptoms and signs of acoustic neurofibromata. Brain 1951;74:144-90.
7. Erickson LS, Sorenson GD, McGavran MH. A review of 140 acoustic neurinomas (neurilemmoma) Laryngoscope 1965;75:601-27.
8. Welling DB, Glasscock ME, Woods CI, et al. Acoustic neuroma: a cost-effective approach. Otolaryngol Head Neck Surg 1990;103:364-70.
9. Selesnick SH, Jackler RK. Atypical hearing loss in acoustic neuroma patients. Laryngoscope 1993;103:437-41.
10. Schlauch RS, Levine S, Li Y, et al. Evaluating hearing threshold differences between ears as a screen for acoustic neuroma. J Speech Hearing Res 1995;38:1168-75.
11. Selter WA, Brackman DE. Acoustic tumor detection with brainstem electric response audiometry. Arch Otolaryngol 1977;103:181-7.
12. Barrs DM, Brackman DE, Olson JE, et al. Changing concepts of acoustic neuroma diagnosis. Arch Otolaryngol 1985;111:17-21.
13. Bauch CD, Olson WO, Harner SG. Auditory brain-stem response and acoustic reflex text. Arch Otolaryngol 1983; 109:522-5.
14. Josey AF, Jackson CG, Glasscock ME. Brainstem evoked response audiometry in confirmed eighth nerve tumors. Am J Otol 1980;1:285-9.
15. Don M, Masuda A, Nelson R, et al. Successful detection of small acoustic tumors using the stacked derived-band auditory brain stem response amplitude. Am L Otol 1997;18:608-21.
16. Telian SA, Kileny PR, Niparko JK, et al. Normal auditory brainstem response in patients with acoustic neuroma. Laryngoscope 1989;99:10-4.
17. Wilson DF, Hodgson RS Gustafson MF, et al. The sensitivity of auditory brainstem response testing in small acoustic neuromas. Laryngoscope 1992;102:961-4.
18. Glasscock ME, Levine SC, McKennan KX. The changing characteristics of acoustic neuroma patients over the 1st 10 years. Laryngoscope 1987;97:1164-7.
19. Chandrasekhar SS, Brackman DE, Dergan KK. Utility of auditory brainstem response audiometry in diagnosis of acoustic neuromas. Am J Otol 1995;16:63-7.
20. Hendrix RA, DeRio RM, Sclafani AP. The use of diagnostic testing in asymmetric sensorineural hearing loss. Otolaryngol Head Neck Surg 1990;103:593-8.
21. Robson AK, Leighton S, Anslow P, et al. MRI as single screening procedure for acoustic neuroma: a cost effective protocol. J R Soc Med 1993;86:455-7.
22. Shelton C, Harnberger HR, Allen R, et al. Fast spin echo magnetic resonance imaging: Clinical application in screening for acoustic neuroma. Otolaryngol Head Neck Surg 1996;114;1:71-6.
23. Allen RW, Harnsberger R, Shelton C, et al. Low-cost high-resolution fast spin-echo MR of acoustic schwannoma: an alternative to enhances conventional spin-echo MR? Am J Neuroradiol 1996;17:1205-10.
24. Hermans R, Van der Goten A, De Doer B, et al. MRI screening for acoustic neuroma without gadolinium: value of 3DFT-CISS sequence. Head Neck Radiol 1997; 39:593-8.
25. Carrier DA, Arriaga MA. Cost-effective evaluation of asymmetric sensorineural hearing loss with focused magnetic resonance imaging. Otolaryngol Head Neck Surg 1997;115:567-73.
26. Wiet RJ, Schuring A. The legal aspects of facial nerve injury. Ear Nose Throat J 1996;75:737-8.
27. Olatunbosun ST, Kaufman JS, Cooper RS, et al. Hypertension in a black population: prevalence and biosocial determinants of high blood pressure in a group of urban Nigerians. J Hum Hypertens 2000;14:249-57.
28. Ibrahim MM, Rizk H, Appel LJ, et al. Hypertension prevalence, awareness, treatment, and control in Egypt. Results from the Egyptian National Hypertension Project (NHP). NHP Investigative Team. Hypertension 1995;26: 886-90.
29. Diez-Roux AV, Northridge ME, Morabia A, et al. Prevalence and social correlates of cardiovascular disease risk factors in Harlem. Am J Public Health 1999;89:302-7.